In the medical community, the word adherence or compliance refers to the degree in which the patient correctly follows medical advice.

More than 131 million or 66% of adults in the United States use prescription medications. This is particularly true for older adults and those living with chronic conditions such as asthma, diabetes, hypertension, hyperlipidemia, depression and more.

According to recent studies, two thirds of all Americans are non-adherent with their medication. This non-adherence accounts for 125,000 premature deaths in the U.S. each year. Non- compliance not only affects patient outcomes but creates 300 billion dollars in avoidable costs to the U.S. health care system annually.

Communication between patients and healthcare providers is one way to improve patient adherence. The importance of proper dosing schedules, side effects and the significance of taking medications when relayed to the patient by a health care team member can be meaningful and helpful.

An additional contributing factor to non-adherence is the inability for patients to pay for medications. In a 2019 poll from Gallup and West Health 58 million Americans had the inability to pay for their medication in the last 12 months. Additionally, 34 million Americans knew at least one friend or family member who had passed away from not being able to afford their medication.

At AlphaScrip and the pharmacy services we provide through Nexus Patient Services, we are committed to improving patient outcomes to medication therapies. We provide benefit verification, co-pay card solutions and direct to patient pharmacy network management to improve affordability and enhance patient access and adherence.

Our communication with patients and ability to connect them with medication programs provides important value to our patients. This communication and connection then can lead to positive outcomes in disease management which is important to both the patient and their clinician.

You can find more information on how we can support your patients in improved adherence and better disease state outcomes at www.alphascrip.com

 

Article by: Lisa King